New antibody shot could help smokers kick the habit
Symptom relief
Recruiting now
This early-stage study tests a new drug called ATI-1013 in 15 healthy smokers. The drug is an antibody designed to bind to nicotine in the body. The main goal is to check if it is safe and how long it stays in the body. Participants get one IV dose of the drug or a placebo and ar…
Phase: PHASE1 • Sponsor: Antidote Therapeutics, Inc • Aim: Symptom relief
Last updated May 04, 2026 02:06 UTC